Looking back at some historical performance on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), we can see that the stock price performance for the last week is 2.78%. Tracking back further over the past month, the stock has performed 20.59%. For the last quarter, shares have performed 11.21%. Going back to the start of the calendar year, company shares are 10.28%. If we scroll back to the full year reading, shares have performed 182.89%. Investors may be trying to figure out if it is a good time to get into a certain stock, or whether to exit a position that has been a loser. Whatever the case, outperforming the market is on the minds of many dedicated equity investors.
We can now shift our focus to some alternate company data on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD). The stock has a current ATR of 0.74. When applying indicators for technical analysis, traders and investors may choose to examine the ATR or average true range. The ATR measures the volatility of a stock on a day-to-day basis. The average true range is typically based on 14 periods and may be calculated daily, weekly, monthly, or intraday. The ATR is not considered a directional indicator, but it may reflect the strength of a particular move. As we move into the second half of the year, investors may be looking to jumpstart their portfolios. Many equity investors may be wondering if the stock markets will find renewed energy and continue higher, or if a major correction is on the horizon.
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) have been recently spotted trading -4.40% off of the 52-week high price. On the other end, company shares have been noted 213.02% away from the low price over the last 52-weeks. Switching over to some distances from popular moving averages, we see that the stock has been recorded 35.16% away from the 200 day moving average. Moving closer, we can see that shares have been trading 11.20% off of the 20-day moving average. Investors may be closely following the current stock price in relation to moving averages. This may assist with figuring out if a breakout or reversal could be in the cards. Knowing when to ride the surge rather than stay on the sidelines, can be a difficult decision even for veteran investors.
Focusing on some other company information, we can see that Amicus Therapeutics, Inc. (NASDAQ:FOLD) has a beta of 1.43. Beta indicates the tendency of a stock’s returns to respond to market swings. A beta of 1 indicates that the stock price moves with the market. A beta under 1 indicates that the stock is less volatile than the market in theory. A beta value over one would indicate the opposite. In terms of volatility, shares have been noted at 8.15% for the week, and 4.59% for the past month. Investors often keep a close eye on any irregular stock volume. Traders and technical analysts have the ability to use volume to help measure the strength of a particular move. Investors may also view volume levels when the stock price is nearing significant support or resistance levels, in order to confirm a breakout in either direction.